Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Natural Killer Index From Hematopoietic Stem Cell Graft [NA]
Clinical trial update on the natural killer index derived from hematopoietic stem cell graft. The study is listed as completed and includes …
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 study of MK-2206 in pediatric patients with recurrent or refractory solid tumors or leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating bone marrow transplantation plus biological therapy for chronic myeloid leukemia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate [Phase 1]
A Phase 1 trial tested dasatinib with cyclosporine in chronic myeloid leukemia patients refractory or intolerant to imatinib. The study stat…
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating STI571 (imatinib) in patients with accelerated-phase chronic myeloid leukemia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy
This completed clinical trial reports mid-to-long-term outcomes for CML patients who achieved complete cytogenetic response on first-line im…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Ondansetron Versus Aprepitant Plus Ondansetron for Emesis [Phase 2]
Phase 2 trial comparing ondansetron alone versus aprepitant plus ondansetron for prevention of emesis in patients with hematologic diseases,…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib
This clinical trial investigates how ABL mutations change over time in patients with chronic myeloid leukemia who failed imatinib and are tr…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib [Phase 3]
This Phase 3 trial compares nilotinib with imatinib in Philadelphia chromosome-positive chronic myeloid leukemia patients in early chronic p…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance [Phase 3]
Phase 3 trial assessing a low-dose combination of nilotinib and imatinib in chronic myeloid leukemia patients with treatment failure, subopt…
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 pediatric study evaluating a plerixafor-containing regimen as part of a second allogeneic stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy [Phase 2]
This is a Phase 2 clinical trial update evaluating PHA-739358 for patients with chronic myeloid leukemia that relapsed after imatinib mesyla…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia [Phase 3]
This update describes a Phase 3 clinical trial evaluating chemotherapy and biological therapy with or without bone marrow or peripheral stem…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation [Phase 1]
A Phase I study evaluating WT1 peptide immunotherapy to induce anti-leukemia immune responses after transplantation was terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma [Phase 2]
A Phase 2 clinical trial update describes using arsenic trioxide to treat patients with recurrent or refractory acute leukemia, chronic myel…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial update of cladribine, cytarabine, and imatinib mesylate in refractory or relapsed acute myeloid leukemia or blastic phase chro…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia [Phase 3]
Phase 3 trial comparing imatinib to interferon-α plus cytarabine in newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemi…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 study evaluating the combination of vorinostat with idarubicin in patients with relapsed or refractory leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes [Phase 1]
Phase 1 trial of the combination therapy 7-Hydroxystaurosporine and perifosine in adults with relapsed or refractory acute leukemias, chroni…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia [Phase 1, Phase 2]
This document reports on a Phase 1/2 clinical trial evaluating the combination of Imatinib Mesylate and Cytarabine in newly diagnosed chroni…
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies [NA]
This clinical trial update indicates that a pilot study of umbilical cord blood transplantation in adults with advanced hematopoietic malign…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Phase 3]
Phase 3 clinical trial update evaluating chemotherapy, interferon, and bone marrow transplantation for chronic myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
The trial evaluating reduced-intensity umbilical cord blood transplantation in adults with advanced hematopoietic malignancies has been term…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
This clinical trial update notes the completion of an unrelated donor stem cell transplantation study in adults with hematopoietic disorders…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies [Phase 1]
Phase 1 pilot study evaluating haploidentical natural killer cell infusions for poor-prognosis non-AML hematologic malignancies has complete…